Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme

Pear Therapeutics has started a limited launch of its digital therapeutic for people living with schizophrenia under the terms of an FDA enforcement holiday during the coronavirus pandemic.

The smartphone-based Pear-004 app will be made available through certain healthcare providers and academic centres under the FDA guidance, which aims to speed up access to digital therapies for people with psychiatric disorders during COVID-19 crisis.

The pandemic means patients with mental illness are less able to maintain contact with healthcare and support workers, placing them under added strain, and the hope is having access to remote tools will help them cope until some degree of normal life can be restored.

full story:

3 Likes

Wow, that’s great news. I know my symptoms have been aggravated by the pandemic even if I’m not worried about it on a conscious level.

Mercy made me download Google Duo for videochat. I’m just gonna set thephone down looking at the ceiling and talk, I don’nt do video anything. I don’t let me kids do video classses either, videos are held forever, not playing that game.